520 related articles for article (PubMed ID: 19041572)
1. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging.
Popović ZB; Kwon DH; Mishra M; Buakhamsri A; Greenberg NL; Thamilarasan M; Flamm SD; Thomas JD; Lever HM; Desai MY
J Am Soc Echocardiogr; 2008 Dec; 21(12):1299-305. PubMed ID: 19041572
[TBL] [Abstract][Full Text] [Related]
2. Myocardial fibrosis and regional function in hypertrophic cardiomyopathy: may the force be with you.
Carasso S; Rakowski H
J Am Soc Echocardiogr; 2008 Dec; 21(12):1306-8. PubMed ID: 19041573
[No Abstract] [Full Text] [Related]
3. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
Maron MS; Appelbaum E; Harrigan CJ; Buros J; Gibson CM; Hanna C; Lesser JR; Udelson JE; Manning WJ; Maron BJ
Circ Heart Fail; 2008 Sep; 1(3):184-91. PubMed ID: 19808288
[TBL] [Abstract][Full Text] [Related]
4. Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging.
Esposito A; De Cobelli F; Perseghin G; Pieroni M; Belloni E; Mellone R; Canu T; Gentinetta F; Scifo P; Chimenti C; Frustaci A; Luzi L; Maseri A; Maschio AD
Heart; 2009 Mar; 95(3):228-33. PubMed ID: 18708417
[TBL] [Abstract][Full Text] [Related]
5. Validation of echocardiographic two-dimensional speckle tracking longitudinal strain imaging for viability assessment in patients with chronic ischemic left ventricular dysfunction and comparison with contrast-enhanced magnetic resonance imaging.
Roes SD; Mollema SA; Lamb HJ; van der Wall EE; de Roos A; Bax JJ
Am J Cardiol; 2009 Aug; 104(3):312-7. PubMed ID: 19616660
[TBL] [Abstract][Full Text] [Related]
6. Feasibility and accuracy of different techniques of two-dimensional speckle based strain and validation with harmonic phase magnetic resonance imaging.
Bansal M; Cho GY; Chan J; Leano R; Haluska BA; Marwick TH
J Am Soc Echocardiogr; 2008 Dec; 21(12):1318-25. PubMed ID: 19041575
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
[TBL] [Abstract][Full Text] [Related]
8. Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications.
Payá E; Marín F; González J; Gimeno JR; Feliu E; Romero A; Ruiz-Espejo F; Roldán V; Climent V; de la Morena G; Valdés M
J Card Fail; 2008 Jun; 14(5):414-9. PubMed ID: 18514934
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].
Dumont CA; Monserrat L; Soler R; Rodríguez E; Fernández X; Peteiro J; Bouzas B; Piñón P; Castro-Beiras A
Rev Esp Cardiol; 2007 Jan; 60(1):15-23. PubMed ID: 17288951
[TBL] [Abstract][Full Text] [Related]
10. Delayed enhancement in hypertrophic cardiomyopathy: comparison with myocardial tagging MRI.
Kim YJ; Choi BW; Hur J; Lee HJ; Seo JS; Kim TH; Choe KO; Ha JW
J Magn Reson Imaging; 2008 May; 27(5):1054-60. PubMed ID: 18425835
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
[TBL] [Abstract][Full Text] [Related]
12. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
[TBL] [Abstract][Full Text] [Related]
13. Regional abnormalities of myocardial deformation in patients with hypertrophic cardiomyopathy: correlations with delayed enhancement in cardiac magnetic resonance.
Ghio S; Revera M; Mori F; Klersy C; Raisaro A; Raineri C; Serio A; Pasotti M; Visconti LO
Eur J Heart Fail; 2009 Oct; 11(10):952-7. PubMed ID: 19789398
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling.
Rudolph A; Abdel-Aty H; Bohl S; Boyé P; Zagrosek A; Dietz R; Schulz-Menger J
J Am Coll Cardiol; 2009 Jan; 53(3):284-91. PubMed ID: 19147047
[TBL] [Abstract][Full Text] [Related]
15. Myocardial fibrosis is associated with biventricular dysfunction in patients with hypertrophic cardiomyopathy.
Prinz C; van Buuren F; Faber L; Bitter T; Bogunovic N; Burchert W; Horstkotte D
Echocardiography; 2012 Apr; 29(4):438-44. PubMed ID: 22150531
[TBL] [Abstract][Full Text] [Related]
16. Symptomatic ventricular tachyarrhythmia is associated with delayed gadolinium enhancement in cardiac magnetic resonance imaging and with elevated plasma brain natriuretic peptide level in hypertrophic cardiomyopathy.
Oka K; Tsujino T; Nakao S; Lee-Kawabata M; Ezumi A; Masai M; Ohyanagi M; Masuyama T
J Cardiol; 2008 Oct; 52(2):146-53. PubMed ID: 18922389
[TBL] [Abstract][Full Text] [Related]
17. Use of quantitative analysis of remote myocardial fibrosis with delayed-enhancement magnetic resonance imaging to predict outcomes after surgical ventricular restoration for ischemic cardiomyopathy.
Takeda K; Matsumiya G; Matsue H; Hamada S; Sakaki M; Sakaguchi T; Fujita T; Sawa Y
J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1514-21. PubMed ID: 19114200
[TBL] [Abstract][Full Text] [Related]
18. Delayed-enhancement MRI of apical hypertrophic cardiomyopathy: assessment of the intramural distribution and comparison with clinical symptoms, ventricular arrhythmias, and cine MRI.
Amano Y; Takayama M; Fukushima Y; Kitamura M; Kumita S
Acta Radiol; 2011 Jul; 52(6):613-8. PubMed ID: 21498307
[TBL] [Abstract][Full Text] [Related]
19. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H
Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610
[TBL] [Abstract][Full Text] [Related]
20. Acute hyperenhancement on delayed contrast-enhanced magnetic resonance imaging is the characteristic sign after coronary microembolization.
Ma JY; Qian JY; Jin H; Chen ZW; Chang SF; Yang S; Sun AJ; Zeng MS; Zou YZ; Ge JB
Chin Med J (Engl); 2009 Mar; 122(6):687-91. PubMed ID: 19323935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
